1. Home
  2. BOLD vs BEEM Comparison

BOLD vs BEEM Comparison

Compare BOLD & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BEEM
  • Stock Information
  • Founded
  • BOLD 2018
  • BEEM 2006
  • Country
  • BOLD United States
  • BEEM United States
  • Employees
  • BOLD N/A
  • BEEM N/A
  • Industry
  • BOLD
  • BEEM Semiconductors
  • Sector
  • BOLD
  • BEEM Technology
  • Exchange
  • BOLD Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • BOLD 33.4M
  • BEEM 31.9M
  • IPO Year
  • BOLD 2024
  • BEEM N/A
  • Fundamental
  • Price
  • BOLD $1.15
  • BEEM $1.82
  • Analyst Decision
  • BOLD Buy
  • BEEM Strong Buy
  • Analyst Count
  • BOLD 4
  • BEEM 3
  • Target Price
  • BOLD $4.00
  • BEEM $4.00
  • AVG Volume (30 Days)
  • BOLD 85.6K
  • BEEM 590.5K
  • Earning Date
  • BOLD 11-05-2025
  • BEEM 11-14-2025
  • Dividend Yield
  • BOLD N/A
  • BEEM N/A
  • EPS Growth
  • BOLD N/A
  • BEEM N/A
  • EPS
  • BOLD N/A
  • BEEM N/A
  • Revenue
  • BOLD N/A
  • BEEM $27,668,000.00
  • Revenue This Year
  • BOLD N/A
  • BEEM N/A
  • Revenue Next Year
  • BOLD N/A
  • BEEM $45.38
  • P/E Ratio
  • BOLD N/A
  • BEEM N/A
  • Revenue Growth
  • BOLD N/A
  • BEEM N/A
  • 52 Week Low
  • BOLD $1.00
  • BEEM $1.33
  • 52 Week High
  • BOLD $3.54
  • BEEM $4.24
  • Technical
  • Relative Strength Index (RSI)
  • BOLD 39.64
  • BEEM 34.68
  • Support Level
  • BOLD $1.17
  • BEEM $1.64
  • Resistance Level
  • BOLD $1.18
  • BEEM $1.76
  • Average True Range (ATR)
  • BOLD 0.07
  • BEEM 0.18
  • MACD
  • BOLD -0.01
  • BEEM -0.00
  • Stochastic Oscillator
  • BOLD 51.79
  • BEEM 24.91

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: